Influence of diabetes on sacubitril/valsartan titration and clinical outcomes in patients hospitalized for heart failure

ConclusionsDespite a higher risk profile among patients with diabetes, sacubitril/valsartan initiation either before or shortly after discharge in hospitalized patients with HFrEF resulted in comparable rates of dose up-titration and tolerability as in those without diabetes.

Source: ESC Heart Failure - September 20, 2022 Category: Cardiology Authors: Klaus K. Witte, Rolf Wachter, Michele Senni, Jan Belohlavek, Ewa Straburzynska ‐Migaj, Candida Fonseca, Eva Lonn, Adele Noè, Heike Schwende, Dmytro Butylin, YannTong Chiang, Domingo Pascual‐Figal, the TRANSITION investigators Tags: Original Article Source Type: research